We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Settings

Save and close

JAX Frontend Platform

BKS.Cg-m +/+ Leprdb/J (000642), one of the most widely used diabetes models at JAX

JAX Notes | July 1, 2008

Who would have thought that a black mouse with a chance mutation would one day become one of the most requested mice in diabetes and obesity research? Such is the case with BKS.Cg- Dock7m +/+ Leprdb/J (000642), a JAX® Mice strain harboring the spontaneous diabetes mutation (db) in the leptin receptor (Lepr) gene. The JAX® Mice Database lists over 300 journal articles with this mouse as a main character. It has played a key role in many research areas, including type 2 diabetes, obesity, endocrine defects, fertility, immunodeficiency, metabolism, cardiovascular, thermoregulation and wound healing. Its popularity as a research tool has resulted in its extensive characterization.

Stock No. 000642

Because Leprdb homozygotes are sterile, we have incorporated the “misty” coat color mutation (m; Dock7m) into our Leprdb colonies to allow genotyping offspring by their appearance. In strain 000642, the db and m alleles are maintained in repulsion – that is, with one mutant allele on each of the two copies of mouse chromosome 4. In this genetic arrangement, homozygous db/db mice (genotype: + db/+ db) are black and fat (not shown), heterozygotes (m +/ + db) used for breeding are black and lean black (upper left), and homozygous Lepr wild-types (m +/m +) are misty (lower right).

Some of this strain’s more notable features include the following:

  • Diabetes phenotypes: transient hyperinsulinemia, insulin resistance, chronic hyperglycemia, glucose intolerance, abnormal islet morphology (Hummel et al. 1966.Science 153:1127-8; Uchida et al. 2005. Nat Med 11:175-82; Yamauchi et al. 2007. Nat Med 13: 332-9); peripheral neuropathy (Raizada et al. 1980. J Biol Chem 255:9149-55; Robertson and Smith. 1980. Diabetes 29:60-7)
  • Exogenous insulin fails to control blood glucose levels (Robertson and Smith. 1980.Diabetes 29:60-7)
  • Renal defects: increased creatinine clearance, decreased albumin secretion (Wendt et al. 2003.Am J Pathol 162:1123-37)
  • Obese by 3-4 weeks of age (Hummel et al. 1966. Science 153:1127-8; Greer. 2006.Am J Physiol Heart Circ Physiol 290 H146-53)
  • Abnormal lipid levels: high HDL, LDL, VLDL, and triglyceride levels (Nishina et al. 1994.Metabolism 43:549-53)
  • Polyphagic (Uchida et al. 2005. Nat Med 11:175-82)
  • Severe liver steatosis (Kanda et al. 2006. J Clin Invest 116:1494-505)
  • Low body temperature (Trayhurn. 1979. Pflugers Arch 380:227-32; Uchida et al. 2005. Nat Med 11:175-82)
  • Increased gluconeogenic enzyme activity (Leiter et al. 1979. In Vitro 15:507-21)
  • Cardiovascular defects (Greer et al. 2006. Am J Physiol Heart Circ Physiol 290:H146-53; How et al. Diabetes 55:466-73)
  • Reproductive defects: sterile, low uterine and ovarian weights, low ovarian hormone production and hypercytolipidemia in follicular granulosa and endometrial epithelial tissue layers (Garris. 2004.Tissue Cell 36:19-28)
  • Increased metabolic efficiency (Trayhurn. 1979. Pflugers Arch 380:227-32)
  • Delayed wound healing (Werner et al. 1994. J Invest Dermatol 103:469-73; Brem et al. 2007. Exp Gerontol 42:523-31)

©2025 The Jackson Laboratory